Prakash Charu
Harvard University, USA.
Int J Technol Assess Health Care. 2003 Winter;19(1):28-40. doi: 10.1017/s0266462303000047.
This study examines the parameters crucial to cost-effectiveness of universal hepatitis B immunization in India. An incremental cost-effectiveness analysis was done using a decision tree (Markov model) to follow up a hypothetical cohort of 100,000 newborns for the effects of hepatitis B acquired vertically at birth. The measure of effectiveness was disability-adjusted life-years gained. Uncertainty analysis and Scenario analysis were done using Latin hypercube sampling. Hepatitis B endemicity is the most important factor, followed by the cost of vaccine. Other factors of some influence are vaccination coverage, vaccine efficacy, HBeAg positivity, and vaccine wastage.
本研究考察了对印度普遍接种乙型肝炎疫苗的成本效益至关重要的参数。采用决策树(马尔可夫模型)进行增量成本效益分析,以追踪一个由100,000名新生儿组成的假设队列,观察其出生时垂直感染乙型肝炎的影响。有效性的衡量指标是获得的伤残调整生命年。使用拉丁超立方抽样进行不确定性分析和情景分析。乙型肝炎的地方流行情况是最重要的因素,其次是疫苗成本。其他有一定影响的因素包括疫苗接种覆盖率、疫苗效力、HBeAg阳性率和疫苗浪费。